Luzano, Charisse O.
HRN: 23-02-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/09/2025
CEFUROXIME 500MG (TAB)
10/09/2025
10/16/2025
PO
500 MG
BID
Acute Uncomplicated Cystitis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes